Cargando…

The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism

PURPOSE: Angiotensin converting enzyme 2 (ACE2) is the door for SARS-CoV-2, expressed in critical metabolic tissues. So, it is rational that the new virus causes pleiotropic alterations in glucose metabolism, resulting in the complication of pre-existing diabetes’s pathophysiology or creating new di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahrooz, Abdolkarim, Muscogiuri, Giovanna, Buzzetti, Raffaella, Maddaloni, Ernesto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060688/ https://www.ncbi.nlm.nih.gov/pubmed/33886062 http://dx.doi.org/10.1007/s12020-021-02729-7

Ejemplares similares

Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19
por: Mahrooz, Abdolkarim
Publicado: (2021)

Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
por: Strollo, Rocky, et al.
Publicado: (2021)

Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes
por: D'Onofrio, Luca, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
por: Maddaloni, Ernesto, et al.
Publicado: (2015)

The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin
por: Kashi, Zahra, et al.
Publicado: (2016)

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
por: D’Onofrio, Luca, et al.
Publicado: (2023)

Effects of the COVID‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
por: D'Onofrio, Luca, et al.
Publicado: (2021)

Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA
por: Tiberti, Claudio, et al.
Publicado: (2022)

Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
por: Maddaloni, Ernesto, et al.
Publicado: (2021)

Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018)

Paraoxonase 1 Activity is Associated with Interleukin-6 Levels in Type 2 Diabetes: Effects of Age and Gender
por: Nikzad, Armin, et al.
Publicado: (2023)

The Atherogenic Index Log (Triglyceride/HDL-Cholesterol) as a Biomarker to Identify Type 2 Diabetes Patients with Poor Glycemic Control
por: Nosrati, Mani, et al.
Publicado: (2021)

Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication
por: Siddiqui, Khalid, et al.
Publicado: (2022)

Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018)

Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications
por: Kianmehr, Anvarsadat, et al.
Publicado: (2021)

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
por: Maddaloni, Ernesto, et al.
Publicado: (2022)

Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
por: Maiorino, Maria Ida, et al.
Publicado: (2023)

Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G>A and the glycemic response following metformin therapy in patients with type 2 diabetes
por: Hosseyni-Talei, Seyyedeh Raheleh, et al.
Publicado: (2017)

Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients
por: Shokri, Fazlollah, et al.
Publicado: (2016)

The Pleiotropic Effects of Glutamine Metabolism in Cancer
por: Bott, Alex J., et al.
Publicado: (2019)

MicroRNAs may provide new strategies in the treatment and diagnosis of diabetic retinopathy: Importance of VEGF
por: Akbari Kordkheyli, Vahid, et al.
Publicado: (2021)

Association between vitamin D receptor gene polymorphism (rs731236) and aggrecan gene VNTR polymorphism with the risk of lumbar intervertebral disc degeneration
por: Haddadi, Kaveh, et al.
Publicado: (2022)

Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin
por: Ghaffari-Cherati, Maryam, et al.
Publicado: (2016)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Complex trait architecture: the pleiotropic model revisited
por: North, T.-L., et al.
Publicado: (2015)

The pleiotropic roles of leptin in metabolism, immunity, and cancer
por: de Candia, Paola, et al.
Publicado: (2021)

Obesity, Autoimmunity, and Double Diabetes in Youth
por: Pozzilli, Paolo, et al.
Publicado: (2011)

The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study
por: Pignatelli, Pasquale, et al.
Publicado: (2022)

Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure
por: Kao, Ting-Wei, et al.
Publicado: (2022)

Pleiotropic Effects of APOB Variants on Lipid Profiles, Metabolic Syndrome, and the Risk of Diabetes Mellitus
por: Jang, Shih-Jung, et al.
Publicado: (2022)

Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents
por: Gentilella, Raffaella, et al.
Publicado: (2019)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice
por: Neto-Ferreira, Rodrigo, et al.
Publicado: (2013)

The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
por: Patel, Dhiren K., et al.
Publicado: (2019)

Complex and pleiotropic signaling pathways regulated by the secreted protein augurin
por: Richter, Margaux, et al.
Publicado: (2023)

Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
por: Pereira, Thiago Melo Costa, et al.
Publicado: (2016)

Noncoding RNA Roles in Pharmacogenomic Responses to Aspirin: New Molecular Mechanisms for an Old Drug
por: Khazeei Tabari, Mohammad Amin, et al.
Publicado: (2021)

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
por: Hawa, Mohammed I., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m09vo99e0o0cl6nusrajl7qpj4